Validating cancer drug targets

被引：107

作者：

Benson, John D. ^{[1
]}

Chen, Ying-Nan P. ^{[1
]}

Cornell-Kennon, Susan A. ^{[1
]}

Dorsch, Marion ^{[1
]}

Kim, Sunkyu ^{[1
]}

Leszczyniecka, Magdalena ^{[1
]}

Sellers, William R. ^{[1
]}

Lengauer, Christoph ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Cambridge, MA 02139 USA

来源：

NATURE | 2006年 / 441卷 / 7092期

关键词：

D O I：

10.1038/nature04873

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

A cancer drug target is only truly validated by demonstrating that a given therapeutic agent is clinically effective and acts through the target against which it was designed. Nevertheless, it is desirable to declare an early-stage drug target as 'validated' before investing in a full-scale drug discovery programme dedicated to it. Although the outcome of validation studies can guide cancer research programmes, strictly defined universal validation criteria have not been established.

引用

页码：451 / 456

页数：6

共 50 条

[1] Validating cancer drug targets
John D. Benson
Ying-Nan P. Chen
Susan A. Cornell-Kennon
Marion Dorsch
Sunkyu Kim
Magdalena Leszczyniecka
William R. Sellers
Christoph Lengauer
Nature, 2006, 441 : 451 - 456
[2] Validating cancer drug targets through chemical genetics
Burkard, Mark E.
Jallepalli, Prasad V.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2010, 1806 (02): : 251 - 257
[3] Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Christopher M. Overall
Oded Kleifeld
Nature Reviews Cancer, 2006, 6 : 227 - 239
[4] Tumour microenvironment - Opinion - Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, CM
Kleifeld, O
NATURE REVIEWS CANCER, 2006, 6 (03) : 227 - 239
[5] Identifying and validating novel analgesic drug targets
Woolf, Clifford J.
ACTA PHARMACOLOGICA SINICA, 2006, 27 : 5 - 5
[6] Challenges in validating candidate therapeutic targets in cancer
Settleman, Jeffrey
Sawyers, Charles L.
Hunter, Tony
ELIFE, 2018, 7
[7] Integrative analysis of PTEN-related hub genes and validating drug targets for colorectal cancer
Wang, Gang
Zhu, Zhi Min
Wang, Kun
PRECISION MEDICAL SCIENCES, 2024, 13 (01): : 4 - 20
[8] Recent advances in identifying and validating drug targets in trypanosomes and leishmanias
Barrett, MP
Mottram, JC
Coombs, GH
TRENDS IN MICROBIOLOGY, 1999, 7 (02) : 82 - 88
[9] The identification of essential cellular genes is critical for validating drug targets
Xu, Ting
Wang, Shuang
Ma, Tingting
Dong, Yawen
Ashby Jr, Charles R.
Hao, Ge-Fei
DRUG DISCOVERY TODAY, 2024, 29 (12)
[10] CANCER DRUG TARGETS ALZHEIMERS
GILLINGS, A
NEW SCIENTIST, 1995, 148 (2005) : 24 - 24

← 1 2 3 4 5 →